Published by Josh White on 6th January 2022
(Sharecast News) - Cancer therapy biotechnology company BiVictriX Therapeutics announced the appointment of Glyn Baker as its chief financial officer on Thursday, in a non-board role.
URL: http://www.digitallook.com/dl/news/story/32375741/...